Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Dowling

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|July 13, 2022
Post CAR-T cytopenia: poorly understood and clinically challengingMark R Dowling, Michael Dickinson
Blood Advances|October 31, 2025
ctDNA MRD after CAR-TSalvatore Fiorenza, Mark R Dowling
Blood|October 2, 2025
DRiving STandard-of-care CAR T cells in real-world GermanyMark R Dowling, Simon J Harrison
Immunology and Cell Biology|March 18, 2009
Modelling naive T-cell homeostasis: consequences of heritable cellular lifespan during ageingMark R Dowling, Philip D Hodgkin
Acta Haematologica|July 18, 2019
Neurological Complications after Allogeneic Transplantation - Can We Do Better?Mark R Dowling, Karen K Ballen
Trends in Immunology|June 23, 2009
Why does the thymus involute? A selection-based hypothesisMark R Dowling, Philip D Hodgkin
Blood Advances|November 14, 2023
ICANS prophylaxis: potentially transformative but elusiveMark R Dowling, Cameron J Turtle
British Journal of Pharmacology|July 19, 2006
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptorMark R Dowling, Steven J Charlton
Journal of the Royal Society, Interface|July 20, 2006
Modelling cell lifespan and proliferation: is likelihood to die or to divide independent of age?Mark R Dowling, Dejan Milutinović, Philip D Hodgkin
British Journal of Pharmacology|November 20, 2016
Endogenous lysophosphatidic acid (LPA<sub>1</sub> ) receptor agonists demonstrate ligand bias between calcium and ERK signalling pathways in human lung fibroblastsAfrah Sattikar, Mark R Dowling, Elizabeth M Rosethorne
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|July 13, 2022
Post CAR-T cytopenia: poorly understood and clinically challengingMark R Dowling, Michael Dickinson
Blood Advances|October 31, 2025
ctDNA MRD after CAR-TSalvatore Fiorenza, Mark R Dowling
Blood|October 2, 2025
DRiving STandard-of-care CAR T cells in real-world GermanyMark R Dowling, Simon J Harrison
Immunology and Cell Biology|March 18, 2009
Modelling naive T-cell homeostasis: consequences of heritable cellular lifespan during ageingMark R Dowling, Philip D Hodgkin
Acta Haematologica|July 18, 2019
Neurological Complications after Allogeneic Transplantation - Can We Do Better?Mark R Dowling, Karen K Ballen
Trends in Immunology|June 23, 2009
Why does the thymus involute? A selection-based hypothesisMark R Dowling, Philip D Hodgkin
Blood Advances|November 14, 2023
ICANS prophylaxis: potentially transformative but elusiveMark R Dowling, Cameron J Turtle
British Journal of Pharmacology|July 19, 2006
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptorMark R Dowling, Steven J Charlton
Journal of the Royal Society, Interface|July 20, 2006
Modelling cell lifespan and proliferation: is likelihood to die or to divide independent of age?Mark R Dowling, Dejan Milutinović, Philip D Hodgkin
British Journal of Pharmacology|November 20, 2016
Endogenous lysophosphatidic acid (LPA<sub>1</sub> ) receptor agonists demonstrate ligand bias between calcium and ERK signalling pathways in human lung fibroblastsAfrah Sattikar, Mark R Dowling, Elizabeth M Rosethorne
Pageof 6